Health-Related Quality of Life Impact in Employees Participating in a Pharmacist-Run Risk Reduction Program by Lenz, Thomas L. et al.
Volume 3 | Number 4 Article 94
2012
Health-Related Quality of Life Impact in
Employees Participating in a Pharmacist-Run Risk
Reduction Program
Thomas L. Lenz
Nicole D. Gillespie
Maryann Z. Skrabal
Michele A. Faulkner
Jessica J. Skradski
See next page for additional authors
Follow this and additional works at: http://pubs.lib.umn.edu/innovations
INNOVATIONS in pharmacy is published by the University of Minnesota Libraries Publishing.
Recommended Citation
Lenz TL, Gillespie ND, Skrabal MZ, et al. Health-Related Quality of Life Impact in Employees Participating in a Pharmacist-Run Risk
Reduction Program. Inov Pharm. 2012;3(4): Article 94. http://pubs.lib.umn.edu/innovations/vol3/iss4/5
Health-Related Quality of Life Impact in Employees Participating in a
Pharmacist-Run Risk Reduction Program
Authors
Thomas L. Lenz, Nicole D. Gillespie, Maryann Z. Skrabal, Michele A. Faulkner, Jessica J. Skradski, Yongyue
Qi, and Abby W. Coleman
This original research is available in INNOVATIONS in pharmacy: http://pubs.lib.umn.edu/innovations/vol3/iss4/5
Original Research PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                        2012, Vol. 3, No. 4, Article 94                          INNOVATIONS in pharmacy   1 
 
Health-Related Quality of Life Impact in Employees Participating in a Pharmacist-Run Risk 
Reduction Program 
Thomas L. Lenz, PharmD; Nicole D. Gillespie, PharmD; Maryann Z. Skrabal, PharmD; Michele A. Faulkner, PharmD; Jessica J. Skradski, 
PharmD; Yongyue Qi; and Abby W. Coleman, PharmD Candidate 
School of Pharmacy and Health Professions, Creighton University 
 
Disclosures:  The authors have no conflicts of interest to disclose 
Key words:  health related quality of life, pharmacist, employee health 
 
Abstract 
Health related quality of life (HRQOL) and self-perceived well-being have been shown to be associated with lower healthcare 
utilization and costs in people with chronic diseases.  A pharmacist-run employee health program started in 2008 sought to improve 
HRQOL through the use of individualized lifestyle behavior programming, medication therapy management, and care coordination 
activities.  Following one year of participation in the program, employee participant’s self-reported general health rating significantly 
improved compared with their baseline rating (p < 0.001).  Participants also reported a significantly lower number of days within a 
month when they did not feel physically and/or mentally well at baseline vs. one-year, respectively (10.3 days vs. 6.0 days, p < 0.01).  
Pharmacists can positively impact self-reported HRQOL when working in an employee health setting. 
 
 
In 1946, the World Health Organization defined health as, “a 
state of complete physical, mental, and social well-being and 
not merely the absence of disease or infirmity.”
1
 Over the 
past seven decades, however, health has been narrowly 
measured in the literature mostly through morbidity and 
mortality outcomes.
2
  The quality of an individual’s life has 
only recently become an important and more frequent 
measure of health. 
 
The Centers for Disease Control and Prevention (CDC) reports 
that quality of life (QOL) is a broad multidimensional concept 
that includes both positive and negative aspects of life as 
perceived by each individual.
2
  Quality of life is defined in 
many different ways by various organizations and can include 
many different aspects of life.
2
  However, the CDC focuses 
more specifically on health-related quality of life (HRQOL), or 
the aspects of overall QOL that effect either physical or 
mental health.
2
 
 
It is known that individuals with chronic diseases and 
disabilities report lower QOL levels and more unhealthy days 
compared with individuals without chronic diseases and 
disabilities.
3
 Recently, data have been published to show that 
a higher level of self-perceived well-being is associated with 
lower health care utilization and costs in individuals with 
chronic conditions.
4
  This may be particularly important to  
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employers as it may affect the overall financial state of an 
organization.  Data exists to show the pharmacists can have a 
positive impact on the QOL of people with chronic 
conditions.
5-7
  However, the authors could not find any data 
demonstrating the impact a pharmacist can have on the QOL 
of individuals in an employee health setting. 
 
The purpose of this analysis is to report the effect that a 
pharmacist can have on the HRQOL at baseline versus one-
year for employees with chronic conditions who participate in 
a pharmacist-run employee health risk reduction program.  
Prior to conducting the analysis, the project was submitted to 
the local Institutional Review Board for approval and 
oversight. The project was considered to be a continuous 
quality improvement measure of the employee risk reduction 
programs, and therefore, oversight was deemed unnecessary. 
 
Methods 
Risk Reduction Programs 
In 2008, a medium sized university in the Midwestern section 
of the United States initiated a pharmacist-run employee 
health Cardiovascular and Diabetes Risk Reduction Program.  
Employees were eligible to volunteer for the program if they 
had an existing diagnosis of hypertension, 
hypercholesterolemia, diabetes mellitus, or a combination, 
thereof.  Employees could participate in the program for as 
long as they remained employed with the university and 
obtained their health care benefits from the employer.  The 
primary outcomes of the program were to (1) reduce the risk 
of experiencing a cardiovascular event within the next 10 
years; (2) improve the lifestyle habits of physical activity, 
healthy eating, stress management, sleeping, alcohol 
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consumption, and tobacco use; (3) improve medication 
adherence; (4) improve quality of life; and (5) improve 
presenteeism (productivity) rates.  
 
Participants in the risk reduction program attended one-on-
one appointments with the pharmacist at least one time per 
month.  Monthly visits consisted of medication therapy 
management activities, implementation and adherence to 
seven personalized lifestyle medicine programs (physical 
activity, healthy eating, stress management, restorative 
sleep, moderate alcohol consumption, tobacco 
abstinence/cessation, and weight control), and chronic 
disease education and care coordination practices.  
Information regarding the care coordination practices within 
the program has been previously published.
8
 
 
In order to achieve the highest level of program adherence 
and success, each participant was provided with educational 
materials, a home blood pressure monitor, a pedometer, 
lifestyle behavior tracking tools, free access to the employer’s 
exercise facilities, monthly support group meetings, and 
access to a licensed mental health care provider.  
Additionally, the employees with diabetes were provided 
with an initial consultation with a dietitian, six hours of 
American Diabetes Association approved education classes, 
and access to point-of-care hemoglobin A1c analyses as 
needed.  Information regarding the interprofessional nature 
of the program and responsibilities of each care provider has 
been previously published.
9
 
 
Individual participant data was collected at baseline and 
annually thereafter.  Collected data consisted of cholesterol, 
blood pressure, and blood glucose lab values, body weight, 
lifestyle behavior activities, medication refill records, HRQOL 
questionnaires, and presenteeism questionnaires.  With the 
permission of the participant, additional health information 
was also obtained from the annual health risk appraisal data 
collected by the employer and/or from the participants other 
health care professionals (ie. physician). 
 
Health Related Quality of Life Analysis 
The questionnaire that was used in the risk reduction 
programs to measure HRQOL is the same questionnaire that 
the CDC has been using since 1993 to measure HRQOL in the 
Behavior Risk Factor Surveillance System (BRFSS), and since 
2000 in the National Health and Nutrition Examination Survey 
(NHANES) .
10
  The set of HRQOL questions is called the 
"Healthy Days Measures" and include the following:
10
  
 
1. Would you say that in general your health is excellent, 
very good, good, fair or poor? 
2. Now thinking about your physical health, which includes 
physical illness and injury, how many days during the 
past 30 days was your physical health not good? 
3. Now thinking about your mental health, which includes 
stress, depression, and problems with emotions, how 
many days during the past 30 days was your mental 
health not good? 
4. During the past 30 days, approximately how many days 
did poor physical or mental health keep you from doing 
your usual activities, such as self-care, work, or 
recreation?  
Question 1 was converted to numerical values for the 
analysis.  The responses of “poor”, “fair”, “good”, “very 
good”, and “excellent” were recorded as “1”, “2”, “3”, “4”, 
and “5”, respectively, in the database for analysis. 
To calculate a “Summary Index” of unhealthy days, the CDC 
has developed a statistically valid procedure and is as follows, 
“Unhealthy days are an estimate of the overall number of 
days during the previous 30 days when the participant felt 
that either his or her physical or mental health was not good. 
To obtain this estimate, responses to questions 2 and 3 are 
combined to calculate a summary index of overall unhealthy 
days, with a logical maximum of 30 unhealthy days. For 
example, a person who reports 4 physically unhealthy days 
and 2 mentally unhealthy days is assigned a value of 6 total 
unhealthy days, and someone who reports 30 physically 
unhealthy days and 30 mentally unhealthy days is assigned 
the maximum of 30 total unhealthy days.”
11
   
Participants 
The “Healthy Days Measures” questionnaire was 
administered to all participants at baseline and annually 
thereafter.  The data reported in this analysis consists of the 
employees who completed the questionnaire at both 
baseline and at one year. 
 
Statistical Analysis 
The statistical analysis for this project used the Wilcoxon 
signed-rank test as a non-parametric test to compare the 
median difference between the two time points.  A p value of 
<0.05 was considered statistically significant. 
 
Results 
From August 2008 through May 2012 a total of 80 employees 
were enrolled in the risk reduction program.  Of these 
individuals, 50 (17 male / 33 female) completed at least one 
year of participation and had matching HRQOL data collected 
at baseline and at one year.  The average age of the 
participants at enrollment was 52.4 years with 32 having an 
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existing diagnosis of hypertension, 35 having hyperlipidemia 
and 18 having diabetes mellitus type 2.  The HRQOL data was 
analyzed for the group as a whole as well as separately for 
those with and without diabetes.  
 
Self-Reported General Health Rating 
Figure 1 illustrates the results of the participant’s self-
reported rating of their general health at baseline versus one-
year (CDC HRQOL question #1).  A statistically significant 
relative increase from 2.82 to 3.40 (+20.6%, p < 0.001) was 
demonstrated in the overall group.  Likewise, the diabetes 
subgroup demonstrated an increase from 2.39 to 3.00 
(+25.5%, p = 0.013), and the non-diabetes subgroup 
increased from 3.06 to 3.63 (+18.6%, p < 0.01) from baseline 
to one-year, respectively.   
 
Additionally, the CDC used data from the 2009 BRFSS to 
estimate the percentage of Americans who rate their general 
health as either “fair” or “poor” in question 1 of the “Healthy 
Days Measures.”
12
  The results from our analysis at baseline 
and at one-year are provided in Table 1 along with the results 
from the 2009 BRFSS, for comparison.
12
  A statistically 
significant improvement was demonstrated for the overall 
group (p = 0.039) and for the diabetes subgroup (p = 0.031).  
The non-diabetes subgroup showed an improvement at one-
year that achieved a value that was better than that reported 
in the 2009 BRFSS, but the change was not statistically 
significant compared with the baseline value (p = 0.687). 
 
Activity Limitation Days 
Table 2 provides the data obtained from question 4 of the 
“Healthy Days Measures” questionnaire that reflects the 
quantity of days where activity limitation exists due to feeling 
physically or mentally unwell.  The overall group, as well as 
both subgroups, demonstrated fewer days where activity was 
limited at one year versus baseline.  The relative decrease in 
days ranged from 45% to over 72%, but the statistical analysis 
did not demonstrate this to be significant.  In each case, 
however, the number of days where activity was limited at 
one year was less than that reported in the 2009 BRFSS for 
the general U.S. population.
12
 
 
Unhealthy Days 
Table 3 provides the data from questions 2 and 3 that list the 
number of self-reported unhealthy days due to feeling unwell 
physically and mentally, respectively.  Improvements were 
demonstrated in both areas for the overall group and in each 
of the subgroups.  The improvements in the number of 
physically unhealthy days, however, were not statistically 
significant, but did achieve values better when compared 
with the national data.
12
  Statistically significant 
improvements were demonstrated with regard to the 
mentally unhealthy days and were likewise at levels better 
than that reported in the national data.
12
 
 
A combination of questions 2 and 3 are referred to by the 
CDC as a summary index and provides a statistically valid 
estimate of the total number of self-reported unhealthy days 
in the previous 30 days with a logical maximum of 30 days 
possible.
11
  Table 4 lists the total estimated unhealthy days at 
baseline versus one-year with a comparison to national data.  
Statistically significant improvements were demonstrated for 
the overall group as well as each subgroup.  Additionally, in 
each analysis the one-year value was better than compared 
to that of the national data reported in the 2009 BRFSS.  Of 
note, the baseline value for individuals with diabetes reflect 
that they feel unhealthy nearly one-half of the days in a 
month, which decreased to less than one-third after one 
year. 
 
Discussion 
Our analysis showed that a pharmacist-run risk reduction 
program conducted in an employee health setting for 
individuals with chronic conditions can significantly improve 
HRQOL measures after one year of participation and 
compared with that reported for the general U.S. adult 
population in the BRFSS.  Little data has been published to 
date that has demonstrates the value of a pharmacist with 
regards to HRQOL working in a non-medication dispensing 
role such as an employee health setting.   
 
In addition to the HRQOL quantitative data presented in this 
analysis, we conducted a focus group session with eight 
participants to obtain qualitative information.  When 
participants were asked about QOL improvements related to 
the programs, responses overwhelmingly favored the one-on-
one meetings with a pharmacist as the most important aspect 
of the program that helped them reach their goals related to 
QOL.  Participants articulated that they feel better both 
physically and mentally overall, have more energy, and feel 
more in control of their current and future health.  
Participants with diabetes also responded that the program 
activities that focused on medication therapy management 
strategies were particularly helpful in making them “feel 
better.”  One participant responded with a quote that is 
particularly representative of the group. “…the program 
makes me feel good, and it is what I like to call that new 
tennis shoe feeling where you feel like you can jump higher 
and run faster.”  An additional important point that 
participants made with regard to QOL is that they feel like the 
program has had a positive effect regarding how they view 
their job.  One participant stated, “I feel better and believe 
that this helps me to be more effective on the job. I haven't 
been sick as frequently as I was before the program, and have 
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missed less work. I believe I am simply a much better 
employee because of the program.” 
 
Improving employee QOL may be financially important to 
employers as well.  A study published recently demonstrated 
a positive relationship between an improvement in an 
employee’s feeling of well-being and the effect on health care 
utilization and costs.
4
  Harrison and colleagues found that a 
statistically significant (p < 0.01) inverse relationship exists 
between self-reported well-being scores and short-term 
health care utilization and spending.  Employee members of a 
health care plan (n=2245) were asked to complete a 
questionnaire that measured well-being on a 100 point 
scale.
4
  When analyzing the health care utilization and 
spending of these individuals over a 12 month time period, 
their results showed that for every one point increase on the 
well-being scale, a 2.2% decrease in hospital admissions was 
demonstrated.
4
  Additionally, every one point increase 
correlated to a 1.7% decrease in emergency room visits, and 
respondents were 1.0% less likely to incur any health care 
costs, in general.
4
  Also, for those who did utilize health care 
resources, individuals with higher well-being scores spent 
significantly less money compared to those with lower well-
being scores (p < 0.01)  which saved the organization money.
4
  
These results lend evidence to the importance of improving 
QOL in an employee health setting with regard to its positive 
financial impact. 
 
Our analysis did not directly measure health care utilization 
and spending for those who participated in the risk reduction 
program.  Therefore, cost savings due to improvements in 
HRQOL cannot be directly reported in this analysis.  Data 
from this analysis show fewer unhealthy days after one year 
of participation in the program which may have a positive 
effect on employee absenteeism and productivity levels.   
 
It should be noted that when comparing our data to that in 
the BRFSS, we did not compare our risk reduction participants 
to a matched cohort in the BRFSS, and therefore exact 
comparisons were not conducted.  However, the values 
reported for the general U.S. population in the BRFSS 
included those of individuals without chronic conditions, 
whereas our analysis only included individuals who had at 
least one chronic condition (hypertension, 
hypercholesterolemia and/or diabetes mellitus).  The CDC 
reports that Americans with chronic diseases and disabilities 
experience more unhealthy days compared to those without 
diseases and disabilities.
3
  Overall, our data showed that after 
one year of participation in a risk reduction program, the 
number of self-reported unhealthy days in the previous 30 
days was less than that reported in the BRFSS for the general 
population that included individuals with and without chronic 
conditions. 
 
The idea of placing a pharmacist in an employee health 
setting is novel and little is known about the effect a 
pharmacist can have in this practice setting.  Direct health 
outcomes are important to measure in any practice, but the 
worksite has additional measures that may be equally as 
important such as QOL, absenteeism,  productivity and 
others.  Limiting measured outcomes to only direct health 
related data is a narrowly viewed focus and does not capture 
the spirit of what it means to be healthy as defined by the 
WHO in 1946.
1
  Employers are increasingly more interested in 
the greater view of health of its employees, because it may 
have significant financial implications related to employee 
health care expenditures, but also productivity and 
absenteeism costs.  A pharmacist working in an employee 
health care setting may have a positive financial impact on 
the organization in the absence of dispensing medications.  
Pharmacists working in an employee health setting may be 
able to improve the health of employees and the financial 
situation of the organization through activities such as 
individual employee medication therapy management, 
lifestyle medicine related activities, and helping employees 
coordinate their health care needs.  Other opportunities for 
pharmacists in this type of setting may include educating 
employees on medical self-care topics, working with the 
employer on their drug formulary, and providing 
immunizations to employees. 
 
Conclusion 
Quality of life is an important part of an individual’s health 
and well-being.  Pharmacists may be able to have a significant 
and positive impact on the health related quality of life of 
individuals who participate in a pharmacist-run employee risk 
reduction program for employees with chronic diseases.  The 
impact of a pharmacist working in this setting may have 
positive financial implications for the employer while 
producing positive health and well-being outcomes for the 
employees. 
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Table 1.  Percentage of participants rating “fair” or “poor” self-reported health at  
baseline vs. one-year and compared with national data. 
 
 *Baseline, % *One-Year, % Actual Difference  
(p value)  
†National, % 
Overall 28.0 12.0 -16.0% 
(p = 0.039)  
15.9 
Diabetes 50.0 16.7 -33.3% 
(p = 0.031)  
45.0 
Non-Diabetes 15.6 9.4 -6.2% 
(p = 0.687)  
13.0 
 
*n for Overall, Diabetes Subgroup and Non-Diabetes subgroup are 50, 18 and 32, respectively 
†2009 Behavior Risk Factor Surveillance System, Reference #12 
 
 
 
 
 
Table 2.  Activity limitation days in the last 30 days at baseline vs. one-year and compared with national data. 
 
 *Baseline, days *One-Year, days Actual, Relative 
Difference  
(p value)  
 
†National, days  
Overall 3.3 1.5 -1.70, -53.8% 
(p = 0.081)  
2.3 
Diabetes 6.3 3.4 -2.81, -45.0% 
(p = 0.293)  
5.0 
Non-Diabetes 1.7 0.5 -1.22, -72.2% 
(p = 0.160)  
2.0 
 
*n for Overall, Diabetes Subgroup and Non-Diabetes subgroup are 50, 18 and 32, respectively 
†2009 Behavior Risk Factor Surveillance System, Reference #12 
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Table 3.  Self-reported physically and mentally unhealthy days in the last 30 days at 
 baseline vs. one-year and compared with national data. 
 
 *Baseline, days *One-Year, days Actual, Relative 
Difference 
(p value)  
 
†National, days 
Physically Unhealthy Days 
Overall (n=50) 4.3 2.9 -1.4, -33.2% 
P = 0.244  
3.6 
Diabetes (n=18) 8.1 5.1 -3.0, -37.0% 
P = 0.312  
8.1 
Non-Diabetes (n=32) 2.1 1.6 0.5, -25.4% 
P = 0.539  
3.2 
Mentally Unhealthy Days 
Overall (n=50) 7.0 3.4 -3.6, -51.1% 
P < 0.01  
3.5 
Diabetes (n=18) 8.4 4.5 -3.9, -46.4% 
P = 0.001  
4.7 
Non-Diabetes (n=32) 6.2 2.8 -3.4, -54.9% 
P = 0.015  
3.4 
 
*n for Overall, Diabetes Subgroup and Non-Diabetes subgroup are 50, 18 and 32, respectively 
†2009 Behavior Risk Factor Surveillance System, Reference #12 
 
 
 
 
 
Table 4.  Total estimated unhealthy days in the previous 30 days at baseline vs. one-year and compared with national data. 
 
 *Baseline, days *One-Year, days Actual, Relative 
Difference  
(p value)  
 
†National, days  
Overall 10.3 6.0 -4.3 days, -42.5% 
(p < 0.01)  
6.2 
Diabetes 14.4 8.9 -5.5 days, -38.1% 
(p = 0.035)  
9.9 
Non-Diabetes 8.0 4.4 -3.6 days, -45.0% 
(p = 0.014)  
5.1 
 
*n for Overall, Diabetes Subgroup and Non-Diabetes subgroup are 50, 18 and 32, respectively 
†2009 Behavior Risk Factor Surveillance System, Reference #12 
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Figure Legend 
Figure 1.  Self-reported general health at baseline vs. one-year.  
 
 
